Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, HARMONY BIOSCIENCES HOLDINGS, INC. reported revenue of $868M, up 21.5% year over year. Operating margin was 24.0% and net margin 18.3%, on a free-cash-flow margin of 40.1% with capital expenditure at 0.0% of revenue. Every figure is computed directly from HRMY's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $868M | 24.0% | 18.3% |
| FY2024 | $715M | 26.7% | 20.4% |
| FY2023 | $582M | 33.0% | 22.1% |
| FY2022 | $438M | 27.4% | 41.4% |
| FY2021 | $305M | 28.7% | 11.3% |
How does HRMY compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.